Novo Nordisk’s weight-loss drug Wegovy could soon have a new sales outlet in the U.S. T elehealth company Hims & Hers Health ...
Food and Drug Administration's Center for Drug Evaluation and Research, George Tidmarsh, resigned on Sunday amid serious ...
Parents and clinicians are urged to review usage of certain health products for young children after federal authorities ...
The FDA's top drug regulator, Dr. George Tidmarsh, quit after federal officials began reviewing "serious concerns about his ...
Stocktwits on MSN
Femasys Stock Sparks Retail Frenzy After FDA Clears Final Phase Of FemBloc Trial And $58M Financing
Femasys secured FDA approval to proceed with the final phase of its pivotal FemBloc trial, a key step toward U.S. market ...
The new operation would include U.S. troops on the ground in Mexico striking drug labs and cartel leaders, according to ...
Food and Drug Administration no longer agreed that clinical data for the Dutch company's gene therapy for Huntington's disease may be adequate for a marketing application, triggering a 57% slump in ...
Alvotech rated Hold after FDA setback for AVT05. Click for my look at ALVO stock prospects and what would make me upgrade it ...
Developers of biosimilars, medicines that are near-identical copies of biologic drugs, will no longer be required to conduct clinical trials to prove effectiveness.
The U.S. Senate reconvened Monday afternoon for a possible funding bill as the federal government shutdown moved one day ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback